{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:36:53Z","timestamp":1791059813273,"version":"4.1.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T00:00:00Z","timestamp":1535328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T00:00:00Z","timestamp":1535328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Microbial signals have been linked to autoantibody induction. Recently, we found that purified anti-CD4 autoantibodies from the plasma of chronic HIV-1-infected patients under viral-suppressed antiretroviral therapy (ART) play a pathologic role in poor CD4+ T cell recovery. The purpose of the study was to investigate the association of systemic microbiome and anti-CD4 autoantibody production in HIV. Plasma microbiome from 12 healthy controls and 22 HIV-infected subjects under viral-suppressed ART were analyzed by MiSeq sequencing. Plasma level of autoantibodies and microbial translocation (LPS, total bacterial 16S rDNA, soluble CD14, and LPS binding protein) were analyzed by ELISA, limulus amebocyte assay, and qPCR. We found that plasma level of anti-CD4 IgGs but not anti-CD8 IgGs was increased in HIV+ subjects compared to healthy controls. HIV+ subjects with plasma anti-CD4 IgG\u2009&gt;\u200950\u2009ng\/mL (high) had reduced microbial diversity compared to HIV+ subjects with anti-CD4 IgG \u2264 50\u2009ng\/mL (low). Moreover, plasma anti-CD4 IgG level was associated with elevated microbial translocation and reduced microbial diversity in HIV+ subjects. The <jats:italic>Alphaproteobacteria<\/jats:italic> class was significantly enriched in HIV+ subjects with low anti-CD4 IgG compared to patients with high anti-CD4 IgG even after controlling for false discovery rate (FDR). The microbial components were different from the phylum to genus level in HIV+ subjects with high anti-CD4 IgGs compared to the other two groups, but these differences were not significant after controlling for FDR. These results suggest that systemic microbial translocation and microbiome may associate with anti-CD4 autoantibody production in ART-treated HIV disease.<\/jats:p>","DOI":"10.1038\/s41598-018-31116-y","type":"journal-article","created":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T11:15:02Z","timestamp":1534850102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Distinct systemic microbiome and microbial translocation are associated with plasma level of anti-CD4 autoantibody in HIV infection"],"prefix":"10.1038","volume":"8","author":[{"given":"Wanli","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Alekseyenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binhua","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya L.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1374-053X","authenticated-orcid":false,"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,27]]},"reference":[{"key":"31116_CR1","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1097\/00002030-200409030-00013","volume":"18","author":"O Keiser","year":"2004","unstructured":"Keiser, O. et al. All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population. AIDS 18, 1835\u20131843 (2004).","journal-title":"AIDS"},{"key":"31116_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","volume":"43","author":"FJ Palella Jr","year":"2006","unstructured":"Palella, F. J. Jr et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 43, 27\u201334, https:\/\/doi.org\/10.1097\/01.qai.0000233310.90484.16 (2006).","journal-title":"J Acquir Immune Defic Syndr"},{"key":"31116_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1097\/QAD.0b013e3282f7cb76","volume":"22","author":"JV Baker","year":"2008","unstructured":"Baker, J. V. et al. CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. Aids 22, 841\u2013848, https:\/\/doi.org\/10.1097\/QAD.0b013e3282f7cb76 (2008).","journal-title":"Aids"},{"key":"31116_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/QAI.0b013e3181576818","volume":"46","author":"C Lewden","year":"2007","unstructured":"Lewden, C. et al. HIV-infected adults with a CD4 cell count greater than 500 cells\/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr 46, 72\u201377, https:\/\/doi.org\/10.1097\/QAI.0b013e318134257a (2007).","journal-title":"J Acquir Immune Defic Syndr"},{"key":"31116_CR5","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1093\/infdis\/jir507","volume":"204","author":"MM Lederman","year":"2011","unstructured":"Lederman, M. M. et al. Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. The Journal of infectious diseases 204, 1217\u20131226, https:\/\/doi.org\/10.1093\/infdis\/jir507 (2011).","journal-title":"The Journal of infectious diseases"},{"key":"31116_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1086\/597093","volume":"48","author":"CF Kelley","year":"2009","unstructured":"Kelley, C. F. et al. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 48, 787\u2013794, https:\/\/doi.org\/10.1086\/597093 (2009).","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"31116_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2174\/157016208783885038","volume":"6","author":"F Gutierrez","year":"2008","unstructured":"Gutierrez, F. et al. Patients\u2019 characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapy. Current HIV research 6, 100\u2013107 (2008).","journal-title":"Current HIV research"},{"key":"31116_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1086\/510746","volume":"44","author":"RD Moore","year":"2007","unstructured":"Moore, R. D. & Keruly, J. C. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 44, 441\u2013446, https:\/\/doi.org\/10.1086\/510746 (2007).","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"31116_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/QAI.0b013e318042e1c3","volume":"45","author":"SH Tuboi","year":"2007","unstructured":"Tuboi, S. H. et al. Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration. J Acquir Immune Defic Syndr 45, 52\u201359, https:\/\/doi.org\/10.1097\/QAI.0b013e318042e1c3 (2007).","journal-title":"J Acquir Immune Defic Syndr"},{"key":"31116_CR10","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1086\/374786","volume":"187","author":"PW Hunt","year":"2003","unstructured":"Hunt, P. W. et al. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. The Journal of infectious diseases 187, 1534\u20131543, https:\/\/doi.org\/10.1086\/374786 (2003).","journal-title":"The Journal of infectious diseases"},{"key":"31116_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.clim.2006.04.570","volume":"120","author":"S Fernandez","year":"2006","unstructured":"Fernandez, S., Price, P., McKinnon, E. J., Nolan, R. C. & French, M. A. Low CD4+ T-cell counts in HIV patients receiving effective antiretroviral therapy are associated with CD4+ T-cell activation and senescence but not with lower effector memory T-cell function. Clinical immunology 120, 163\u2013170, https:\/\/doi.org\/10.1016\/j.clim.2006.04.570 (2006).","journal-title":"Clinical immunology"},{"key":"31116_CR12","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1086\/429670","volume":"191","author":"O Benveniste","year":"2005","unstructured":"Benveniste, O. et al. Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads. J Infect Dis 191, 1670\u20131679, https:\/\/doi.org\/10.1086\/429670 (2005).","journal-title":"J Infect Dis"},{"key":"31116_CR13","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1097\/01.aids.0000242819.72839.db","volume":"20","author":"G Marchetti","year":"2006","unstructured":"Marchetti, G. et al. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART. Aids 20, 1727\u20131736, https:\/\/doi.org\/10.1097\/01.aids.0000242819.72839.db (2006).","journal-title":"Aids"},{"key":"31116_CR14","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1097\/QAD.0b013e3283112d29","volume":"22","author":"G Marchetti","year":"2008","unstructured":"Marchetti, G. et al. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. Aids 22, 2035\u20132038, https:\/\/doi.org\/10.1097\/QAD.0b013e3283112d29 (2008).","journal-title":"Aids"},{"key":"31116_CR15","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1086\/656369","volume":"202","author":"R Rajasuriar","year":"2010","unstructured":"Rajasuriar, R. et al. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor alpha and microbial translocation. J Infect Dis 202, 1254\u20131264, https:\/\/doi.org\/10.1086\/656369 (2010).","journal-title":"J Infect Dis"},{"key":"31116_CR16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/01.qai.0000226789.51992.3f","volume":"42","author":"RT Gandhi","year":"2006","unstructured":"Gandhi, R. T. et al. Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. J Acquir Immune Defic Syndr 42, 426\u2013434, https:\/\/doi.org\/10.1097\/01.qai.0000226789.51992.3f (2006).","journal-title":"J Acquir Immune Defic Syndr"},{"key":"31116_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/00126334-200306010-00002","volume":"33","author":"KB Anthony","year":"2003","unstructured":"Anthony, K. B. et al. Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover. J Acquir Immune Defic Syndr 33, 125\u2013133 (2003).","journal-title":"J Acquir Immune Defic Syndr"},{"key":"31116_CR18","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1097\/00002030-200209270-00002","volume":"16","author":"H Valdez","year":"2002","unstructured":"Valdez, H. et al. Limited immune restoration after 3 years\u2019 suppression of HIV-1 replication in patients with moderately advanced disease. AIDS 16, 1859\u20131866 (2002).","journal-title":"AIDS"},{"key":"31116_CR19","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1086\/651689","volume":"50","author":"E Negredo","year":"2010","unstructured":"Negredo, E. et al. Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 50, 1300\u20131308, https:\/\/doi.org\/10.1086\/651689 (2010).","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"31116_CR20","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/00002030-200109280-00002","volume":"15","author":"L Teixeira","year":"2001","unstructured":"Teixeira, L. et al. Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. Aids 15, 1749\u20131756 (2001).","journal-title":"Aids"},{"key":"31116_CR21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/jac\/dkp248","volume":"64","author":"S Molina-Pinelo","year":"2009","unstructured":"Molina-Pinelo, S. et al. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation. J Antimicrob Chemother 64, 579\u2013588, https:\/\/doi.org\/10.1093\/jac\/dkp248 (2009).","journal-title":"J Antimicrob Chemother"},{"key":"31116_CR22","doi-asserted-by":"publisher","unstructured":"Luo Z. W. et al. Pathological role of anti-CD4 antibodies in HIV-infected immunologic non-responders under viral suppressive antiretroviral therapy. Journal of Infectious Diseases Epub ahead of print, https:\/\/doi.org\/10.1093\/infdis\/jix223 (2017).","DOI":"10.1093\/infdis\/jix223"},{"key":"31116_CR23","doi-asserted-by":"publisher","first-page":"e0167640","DOI":"10.1371\/journal.pone.0167640","volume":"12","author":"Z Luo","year":"2017","unstructured":"Luo, Z. et al. Increased Natural Killer Cell Activation in HIV-Infected Immunologic Non-Responders Correlates with CD4+ T Cell Recovery after Antiretroviral Therapy and Viral Suppression. PLoS One 12, e0167640, https:\/\/doi.org\/10.1371\/journal.pone.0167640 (2017).","journal-title":"PLoS One"},{"key":"31116_CR24","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1182\/blood-2005-11-013383","volume":"108","author":"K Titanji","year":"2006","unstructured":"Titanji, K. et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 108, 1580\u20131587 (2006).","journal-title":"Blood"},{"key":"31116_CR25","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/00002030-200105250-00003","volume":"15","author":"A De Milito","year":"2001","unstructured":"De Milito, A., Morch, C., Sonnerborg, A. & Chiodi, F. Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS (London, England) 15, 957\u2013964 (2001).","journal-title":"AIDS (London, England)"},{"key":"31116_CR26","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1182\/blood-2003-07-2375","volume":"103","author":"A De Milito","year":"2004","unstructured":"De Milito, A. et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 103, 2180\u20132186 (2004).","journal-title":"Blood"},{"key":"31116_CR27","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1097\/01.aids.0000191231.54170.89","volume":"19","author":"K Titanji","year":"2005","unstructured":"Titanji, K. et al. Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions. AIDS (London, England) 19, 1947\u20131955 (2005).","journal-title":"AIDS (London, England)"},{"key":"31116_CR28","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1073\/pnas.0813392106","volume":"106","author":"Y Guan","year":"2009","unstructured":"Guan, Y. et al. Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection. Proceedings of the National Academy of Sciences of the United States of America 106, 3952\u20133957 (2009).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"31116_CR29","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.4049\/jimmunol.170.12.5965","volume":"170","author":"A Malaspina","year":"2003","unstructured":"Malaspina, A. et al. Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function. J Immunol 170, 5965\u20135972 (2003).","journal-title":"J Immunol"},{"key":"31116_CR30","doi-asserted-by":"publisher","first-page":"7837","DOI":"10.1128\/JVI.00660-08","volume":"82","author":"W Jiang","year":"2008","unstructured":"Jiang, W. et al. Impaired naive and memory B-cell responsiveness to TLR9 stimulation in human immunodeficiency virus infection. J Virol 82, 7837\u20137845, https:\/\/doi.org\/10.1128\/JVI.00660-08 (2008).","journal-title":"J Virol"},{"key":"31116_CR31","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.vaccine.2015.12.038","volume":"34","author":"Z Luo","year":"2016","unstructured":"Luo, Z. et al. Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination. Vaccine 34, 1945\u20131955, https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.038 (2016).","journal-title":"Vaccine"},{"key":"31116_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/infdis\/jiu409","volume":"211","author":"DM Dinh","year":"2015","unstructured":"Dinh, D. M. et al. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J Infect Dis 211, 19\u201327, https:\/\/doi.org\/10.1093\/infdis\/jiu409 (2015).","journal-title":"J Infect Dis"},{"key":"31116_CR33","doi-asserted-by":"publisher","first-page":"e1003829","DOI":"10.1371\/journal.ppat.1003829","volume":"10","author":"EA Mutlu","year":"2014","unstructured":"Mutlu, E. A. et al. A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects. PLoS Pathog 10, e1003829, https:\/\/doi.org\/10.1371\/journal.ppat.1003829 (2014).","journal-title":"PLoS Pathog"},{"key":"31116_CR34","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1097\/QAD.0000000000000869","volume":"29","author":"P Nowak","year":"2015","unstructured":"Nowak, P. et al. Gut microbiota diversity predicts immune status in HIV-1 infection. AIDS 29, 2409\u20132418, https:\/\/doi.org\/10.1097\/QAD.0000000000000869 (2015).","journal-title":"AIDS"},{"key":"31116_CR35","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.20.1.21526","volume":"20","author":"MJ Villanueva-Millan","year":"2017","unstructured":"Villanueva-Millan, M. J., Perez-Matute, P., Recio-Fernandez, E., Lezana Rosales, J. M. & Oteo, J. A. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients. J Int AIDS Soc 20, 21526, https:\/\/doi.org\/10.7448\/IAS.20.1.21526 (2017).","journal-title":"J Int AIDS Soc"},{"key":"31116_CR36","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/eji.201344283","volume":"44","author":"BR Umiker","year":"2014","unstructured":"Umiker, B. R. et al. Dosage of X-linked Toll-like receptor 8 determines gender differences in the development of systemic lupus erythematosus. European journal of immunology 44, 1503\u20131516, https:\/\/doi.org\/10.1002\/eji.201344283 (2014).","journal-title":"European journal of immunology"},{"key":"31116_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2249.2009.04036.x","volume":"159","author":"CK Wong","year":"2010","unstructured":"Wong, C. K. et al. Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus. Clin Exp Immunol 159, 11\u201322, https:\/\/doi.org\/10.1111\/j.1365-2249.2009.04036.x (2010).","journal-title":"Clin Exp Immunol"},{"key":"31116_CR38","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1172\/JCI30065","volume":"118","author":"DL Thibault","year":"2008","unstructured":"Thibault, D. L. et al. IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. The Journal of clinical investigation 118, 1417\u20131426, https:\/\/doi.org\/10.1172\/JCI30065 (2008).","journal-title":"The Journal of clinical investigation"},{"key":"31116_CR39","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/nm1511","volume":"12","author":"JM Brenchley","year":"2006","unstructured":"Brenchley, J. M. et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature medicine 12, 1365\u20131371 (2006).","journal-title":"Nature medicine"},{"key":"31116_CR40","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1006\/clim.2001.5054","volume":"100","author":"H Nagase","year":"2001","unstructured":"Nagase, H. et al. Mechanism of hypergammaglobulinemia by HIV infection: circulating memory B-cell reduction with plasmacytosis. Clinical immunology Orlando, Fla 100, 250\u2013259 (2001).","journal-title":"Clinical immunology (Orlando, Fla"},{"key":"31116_CR41","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1086\/597476","volume":"199","author":"W Jiang","year":"2009","unstructured":"Jiang, W. et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 199, 1177\u20131185, https:\/\/doi.org\/10.1086\/597476 (2009).","journal-title":"J Infect Dis"},{"key":"31116_CR42","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.1128\/JVI.00017-14","volume":"88","author":"W Jiang","year":"2014","unstructured":"Jiang, W. et al. Cycling memory CD4+ T cells in HIV disease have a diverse T cell receptor repertoire and a phenotype consistent with bystander activation. J Virol 88, 5369\u20135380, https:\/\/doi.org\/10.1128\/JVI.00017-14 (2014).","journal-title":"J Virol"},{"key":"31116_CR43","doi-asserted-by":"publisher","first-page":"11430","DOI":"10.1128\/JVI.00682-14","volume":"88","author":"L Zhang","year":"2014","unstructured":"Zhang, L. et al. Plasmacytoid dendritic cells mediate synergistic effects of HIV and lipopolysaccharide on CD27+ IgD- memory B cell apoptosis. Journal of virology 88, 11430\u201311441, https:\/\/doi.org\/10.1128\/JVI.00682-14 (2014).","journal-title":"Journal of virology"},{"key":"31116_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1471-2180-8-125","volume":"8","author":"SE Dowd","year":"2008","unstructured":"Dowd, S. E. et al. Evaluation of the bacterial diversity in the feces of cattle using 16S rDNA bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP). BMC Microbiol 8, 125, https:\/\/doi.org\/10.1186\/1471-2180-8-125 (2008).","journal-title":"BMC Microbiol"},{"key":"31116_CR45","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1089\/fpd.2008.0107","volume":"5","author":"SE Dowd","year":"2008","unstructured":"Dowd, S. E., Sun, Y., Wolcott, R. D., Domingo, A. & Carroll, J. A. Bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP) for microbiome studies: bacterial diversity in the ileum of newly weaned Salmonella-infected pigs. Foodborne Pathog Dis 5, 459\u2013472, https:\/\/doi.org\/10.1089\/fpd.2008.0107 (2008).","journal-title":"Foodborne Pathog Dis"},{"key":"31116_CR46","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1038\/jid.2011.168","volume":"131","author":"KA Capone","year":"2011","unstructured":"Capone, K. A., Dowd, S. E., Stamatas, G. N. & Nikolovski, J. Diversity of the human skin microbiome early in life. J Invest Dermatol 131, 2026\u20132032, https:\/\/doi.org\/10.1038\/jid.2011.168 (2011).","journal-title":"J Invest Dermatol"},{"key":"31116_CR47","doi-asserted-by":"publisher","first-page":"e26732","DOI":"10.1371\/journal.pone.0026732","volume":"6","author":"AM Eren","year":"2011","unstructured":"Eren, A. M. et al. Exploring the diversity of Gardnerella vaginalis in the genitourinary tract microbiota of monogamous couples through subtle nucleotide variation. PLoS One 6, e26732, https:\/\/doi.org\/10.1371\/journal.pone.0026732 (2011).","journal-title":"PLoS One"},{"key":"31116_CR48","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ismej.2010.162","volume":"5","author":"KS Swanson","year":"2011","unstructured":"Swanson, K. S. et al. Phylogenetic and gene-centric metagenomics of the canine intestinal microbiome reveals similarities with humans and mice. ISME J 5, 639\u2013649, https:\/\/doi.org\/10.1038\/ismej.2010.162 (2011).","journal-title":"ISME J"},{"key":"31116_CR49","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1128\/AEM.03006-05","volume":"72","author":"TZ DeSantis","year":"2006","unstructured":"DeSantis, T. Z. et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 72, 5069\u20135072, https:\/\/doi.org\/10.1128\/AEM.03006-05 (2006).","journal-title":"Appl Environ Microbiol"},{"key":"31116_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","volume":"1","author":"KJ Rothman","year":"1990","unstructured":"Rothman, K. J. No adjustments are needed for multiple comparisons. Epidemiology 1, 43\u201346 (1990).","journal-title":"Epidemiology"},{"key":"31116_CR51","unstructured":"Team, R. C. R: A language and environment for statistical computing. R Foundation for Statistical Computing (2016)."},{"key":"31116_CR52","unstructured":"Jari Oksanen, F. G. B. et al. Eduard Szoecs and Helene Wagner vegan: Community Ecology Package. R package version 2.4\u20131. doi:CRAN.R-project.org\/package=vegan (2016)."},{"key":"31116_CR53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1128\/mBio.01548-14","volume":"5","author":"A Hevia","year":"2014","unstructured":"Hevia, A. et al. Intestinal Dysbiosis Associated with Systemic Lupus Erythematosus. mBio 5, 14, https:\/\/doi.org\/10.1128\/mbio.01548-14 (2014).","journal-title":"mBio"},{"key":"31116_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-016-0146-9","volume":"8","author":"Z He","year":"2016","unstructured":"He, Z., Shao, T., Li, H., Xie, Z. & Wen, C. Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus. Gut pathogens 8, 64, https:\/\/doi.org\/10.1186\/s13099-016-0146-9 (2016).","journal-title":"Gut pathogens"},{"key":"31116_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/QAD.0000000000000006","volume":"28","author":"V Sheikh","year":"2014","unstructured":"Sheikh, V. et al. Graves\u2019 disease as immune reconstitution disease in HIV-positive patients is associated with naive and primary thymic emigrant CD4(+) T-cell recovery. AIDS 28, 31\u201339, https:\/\/doi.org\/10.1097\/QAD.0000000000000006 (2014).","journal-title":"AIDS"},{"key":"31116_CR56","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/1545109712462068","volume":"12","author":"I Shah","year":"2013","unstructured":"Shah, I. Immune thrombocytopenic purpura: a presentation of HIV infection. Journal of the International Association of Providers of AIDS Care 12, 95\u201397, https:\/\/doi.org\/10.1177\/1545109712462068 (2013).","journal-title":"Journal of the International Association of Providers of AIDS Care"},{"key":"31116_CR57","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1089\/thy.2012.0055","volume":"22","author":"R Visser","year":"2012","unstructured":"Visser, R., de Mast, Q., Netea-Maier, R. T. & van der Ven, A. J. Hashimoto\u2019s thyroiditis presenting as acute painful thyroiditis and as a manifestation of an immune reconstitution inflammatory syndrome in a human immunodeficiency virus-seropositive patient. Thyroid: official journal of the American Thyroid Association 22, 853\u2013855, https:\/\/doi.org\/10.1089\/thy.2012.0055 (2012).","journal-title":"Thyroid: official journal of the American Thyroid Association"},{"key":"31116_CR58","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1172\/JCI73441","volume":"124","author":"M Bonsignori","year":"2014","unstructured":"Bonsignori, M. et al. An autoreactive antibody from an SLE\/HIV-1 individual broadly neutralizes HIV-1. The Journal of clinical investigation 124, 1835\u20131843, https:\/\/doi.org\/10.1172\/JCI73441 (2014).","journal-title":"The Journal of clinical investigation"},{"key":"31116_CR59","doi-asserted-by":"publisher","first-page":"e1000107","DOI":"10.1371\/journal.pmed.1000107","volume":"6","author":"MC Levesque","year":"2009","unstructured":"Levesque, M. C. et al. Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS medicine 6, e1000107, https:\/\/doi.org\/10.1371\/journal.pmed.1000107 (2009).","journal-title":"PLoS medicine"},{"key":"31116_CR60","doi-asserted-by":"publisher","first-page":"e1000372","DOI":"10.1371\/journal.ppat.1000372","volume":"5","author":"T Kuwata","year":"2009","unstructured":"Kuwata, T. et al. Association of progressive CD4(+) T cell decline in SIV infection with the induction of autoreactive antibodies. PLoS pathogens 5, e1000372, https:\/\/doi.org\/10.1371\/journal.ppat.1000372 (2009).","journal-title":"PLoS pathogens"},{"key":"31116_CR61","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.imlet.2005.02.018","volume":"99","author":"D Stahl","year":"2005","unstructured":"Stahl, D. et al. Alterations of self-reactive antibody repertoires in HIV disease: an insight into the role of T cells in the selection of autoreactive B cells. Immunol Lett 99, 198\u2013208, https:\/\/doi.org\/10.1016\/j.imlet.2005.02.018 (2005).","journal-title":"Immunol Lett"},{"key":"31116_CR62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1651-2227.1994.tb13331.x","volume":"400","author":"M Rodriguez-Mahou","year":"1994","unstructured":"Rodriguez-Mahou, M. et al. Autoimmune phenomena in children with human immunodeficiency virus infection and acquired immunodeficiency syndrome. Acta paediatrica 400, 31\u201334 (1994).","journal-title":"Acta paediatrica"},{"key":"31116_CR63","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/gut.2003.027854","volume":"53","author":"DE Nilssen","year":"2004","unstructured":"Nilssen, D. E., Oktedalen, O. & Brandtzaeg, P. Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy. Gut 53, 487\u2013493 (2004).","journal-title":"Gut"},{"key":"31116_CR64","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.4049\/jimmunol.0803219","volume":"183","author":"A Lartigue","year":"2009","unstructured":"Lartigue, A. et al. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus. Journal of immunology 183, 6207\u20136216, https:\/\/doi.org\/10.4049\/jimmunol.0803219 (2009).","journal-title":"Journal of immunology"},{"key":"31116_CR65","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.4049\/jimmunol.1402690","volume":"194","author":"N Simchoni","year":"2015","unstructured":"Simchoni, N. & Cunningham-Rundles, C. TLR7- and TLR9-Responsive Human B Cells Share Phenotypic and Genetic Characteristics. J Immunol 194, 3035\u20133044, https:\/\/doi.org\/10.4049\/jimmunol.1402690 (2015).","journal-title":"J Immunol"},{"key":"31116_CR66","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3899\/jrheum.100713","volume":"38","author":"R du Toit","year":"2011","unstructured":"du Toit, R., Whitelaw, D., Taljaard, J. J., du Plessis, L. & Esser, M. Lack of specificity of anticyclic citrullinated peptide antibodies in advanced human immunodeficiency virus infection. J Rheumatol 38, 1055\u20131060, https:\/\/doi.org\/10.3899\/jrheum.100713 (2011).","journal-title":"J Rheumatol"},{"key":"31116_CR67","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.molimm.2004.07.003","volume":"42","author":"G Fust","year":"2005","unstructured":"Fust, G. et al. Antibodies against heat shock proteins and cholesterol in HIV infection. Mol Immunol 42, 79\u201385, https:\/\/doi.org\/10.1016\/j.molimm.2004.07.003 (2005).","journal-title":"Mol Immunol"},{"key":"31116_CR68","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00042560-200108150-00015","volume":"27","author":"I Pereda","year":"2001","unstructured":"Pereda, I. et al. Antitissue transglutaminase antibodies in HIV infection and effect of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 27, 507\u2013508 (2001).","journal-title":"J Acquir Immune Defic Syndr"},{"key":"31116_CR69","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/S0171-2985(01)80004-8","volume":"203","author":"A Horvath","year":"2001","unstructured":"Horvath, A. et al. High level of anticholesterol antibodies (ACHA) in HIV patients. Normalization of serum ACHA concentration after introduction of HAART. Immunobiology 203, 756\u2013768, https:\/\/doi.org\/10.1016\/S0171-2985(01)80004-8 (2001).","journal-title":"Immunobiology"},{"key":"31116_CR70","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1084\/jem.20150585","volume":"212","author":"NS Kolhatkar","year":"2015","unstructured":"Kolhatkar, N. S. et al. Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome. J Exp Med 212, 1663\u20131677, https:\/\/doi.org\/10.1084\/jem.20150585 (2015).","journal-title":"J Exp Med"},{"key":"31116_CR71","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S1568-9972(02)00086-1","volume":"1","author":"G Zandman-Goddard","year":"2002","unstructured":"Zandman-Goddard, G. & Shoenfeld, Y. HIV and autoimmunity. Autoimmun Rev 1, 329\u2013337 (2002).","journal-title":"Autoimmun Rev"},{"key":"31116_CR72","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.autrev.2014.04.005","volume":"13","author":"L Iordache","year":"2014","unstructured":"Iordache, L. et al. Autoimmune diseases in HIV-infected patients: 52 cases and literature review. Autoimmun Rev 13, 850\u2013857, https:\/\/doi.org\/10.1016\/j.autrev.2014.04.005 (2014).","journal-title":"Autoimmun Rev"},{"key":"31116_CR73","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/trf.13477","volume":"56","author":"S Paisse","year":"2016","unstructured":"Paisse, S. et al. Comprehensive description of blood microbiome from healthy donors assessed by 16S targeted metagenomic sequencing. Transfusion 56, 1138\u20131147, https:\/\/doi.org\/10.1111\/trf.13477 (2016).","journal-title":"Transfusion"},{"key":"31116_CR74","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1177\/0884533615609896","volume":"30","author":"GM Barlow","year":"2015","unstructured":"Barlow, G. M., Yu, A. & Mathur, R. Role of the Gut Microbiome in Obesity and Diabetes Mellitus. Nutr Clin Pract 30, 787\u2013797, https:\/\/doi.org\/10.1177\/0884533615609896 (2015).","journal-title":"Nutr Clin Pract"},{"key":"31116_CR75","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1586\/17474124.2015.1051029","volume":"9","author":"R Mathur","year":"2015","unstructured":"Mathur, R. & Barlow, G. M. Obesity and the microbiome. Expert Rev Gastroenterol Hepatol 9, 1087\u20131099, https:\/\/doi.org\/10.1586\/17474124.2015.1051029 (2015).","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"31116_CR76","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000470892","volume":"33","author":"MT Chiriac","year":"2017","unstructured":"Chiriac, M. T., Mahapatro, M., Neurath, M. F. & Becker, C. The Microbiome in Visceral Medicine: Inflammatory Bowel Disease, Obesity and Beyond. Visc Med 33, 153\u2013162, https:\/\/doi.org\/10.1159\/000470892 (2017).","journal-title":"Visc Med"},{"key":"31116_CR77","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00108-017-0229-9","volume":"58","author":"SC Bischoff","year":"2017","unstructured":"Bischoff, S. C. [The intestinal microbiome and metabolic diseases: From obesity to diabetes and nonalcoholic steatohepatitis]. Internist (Berl) 58, 441\u2013448, https:\/\/doi.org\/10.1007\/s00108-017-0229-9 (2017).","journal-title":"Internist (Berl)"},{"key":"31116_CR78","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1053\/j.gastro.2016.12.048","volume":"152","author":"KE Bouter","year":"2017","unstructured":"Bouter, K. E., van Raalte, D. H., Groen, A. K. & Nieuwdorp, M. Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction. Gastroenterology 152, 1671\u20131678, https:\/\/doi.org\/10.1053\/j.gastro.2016.12.048 (2017).","journal-title":"Gastroenterology"},{"key":"31116_CR79","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.chom.2016.02.011","volume":"19","author":"CL Monaco","year":"2016","unstructured":"Monaco, C. L. et al. Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome. Cell host & microbe 19, 311\u2013322, https:\/\/doi.org\/10.1016\/j.chom.2016.02.011 (2016).","journal-title":"Cell host & microbe"},{"key":"31116_CR80","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/hep.28829","volume":"64","author":"B Lelouvier","year":"2016","unstructured":"Lelouvier, B. et al. Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis. Hepatology 64, 2015\u20132027, https:\/\/doi.org\/10.1002\/hep.28829 (2016).","journal-title":"Hepatology"},{"key":"31116_CR81","doi-asserted-by":"publisher","first-page":"e1006048","DOI":"10.1371\/journal.ppat.1006048","volume":"12","author":"AJ Ericsen","year":"2016","unstructured":"Ericsen, A. J. et al. Microbial Translocation and Inflammation Occur in Hyperacute Immunodeficiency Virus Infection and Compromise Host Control of Virus Replication. PLoS Pathog 12, e1006048, https:\/\/doi.org\/10.1371\/journal.ppat.1006048 (2016).","journal-title":"PLoS Pathog"},{"key":"31116_CR82","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/BOR.0000000000000398","volume":"29","author":"Y Segal","year":"2017","unstructured":"Segal, Y., Calabro, M., Kanduc, D. & Shoenfeld, Y. Human papilloma virus and lupus: the virus, the vaccine and the disease. Current opinion in rheumatology 29, 331\u2013342, https:\/\/doi.org\/10.1097\/BOR.0000000000000398 (2017).","journal-title":"Current opinion in rheumatology"},{"key":"31116_CR83","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.imlet.2008.08.007","volume":"121","author":"X Qing","year":"2008","unstructured":"Qing, X. et al. Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury. Immunol Lett 121, 61\u201373, https:\/\/doi.org\/10.1016\/j.imlet.2008.08.007 (2008).","journal-title":"Immunol Lett"},{"key":"31116_CR84","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1007\/s11033-012-1501-7","volume":"39","author":"JX Zhai","year":"2012","unstructured":"Zhai, J. X. et al. PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL\/lpr mice. Mol Biol Rep 39, 6763\u20136771, https:\/\/doi.org\/10.1007\/s11033-012-1501-7 (2012).","journal-title":"Mol Biol Rep"},{"key":"31116_CR85","doi-asserted-by":"publisher","unstructured":"Zhang, Y. et al. The glycan-mediated mechanism on the interactions of gp120 with CD4 and antibody: Insights from molecular dynamics simulation. Chem Biol Drug Des, https:\/\/doi.org\/10.1111\/cbdd.13045 (2017).","DOI":"10.1111\/cbdd.13045"},{"key":"31116_CR86","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1093\/rheumatology\/kex239","volume":"56","author":"D Alpizar-Rodriguez","year":"2017","unstructured":"Alpizar-Rodriguez, D., Pluchino, N., Canny, G., Gabay, C. & Finckh, A. The role of female hormonal factors in the development of rheumatoid arthritis. Rheumatology (Oxford) 56, 1254\u20131263, https:\/\/doi.org\/10.1093\/rheumatology\/kew318 (2017).","journal-title":"Rheumatology (Oxford)"},{"key":"31116_CR87","first-page":"567","volume":"58","author":"G Afshan","year":"2012","unstructured":"Afshan, G., Afzal, N. & Qureshi, S. CD4+ CD25(hi) regulatory T cells in healthy males and females mediate gender difference in the prevalence of autoimmune diseases. Clinical laboratory 58, 567\u2013571 (2012).","journal-title":"Clinical laboratory"},{"key":"31116_CR88","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1126\/science.1124978","volume":"312","author":"P Pisitkun","year":"2006","unstructured":"Pisitkun, P. et al. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312, 1669\u20131672, https:\/\/doi.org\/10.1126\/science.1124978 (2006).","journal-title":"Science"},{"issue":"Suppl 2","key":"31116_CR89","doi-asserted-by":"publisher","first-page":"ii56","DOI":"10.1136\/annrheumdis-2012-202351","volume":"72","author":"OJ Rullo","year":"2013","unstructured":"Rullo, O. J. & Tsao, B. P. Recent insights into the genetic basis of systemic lupus erythematosus. Annals of the rheumatic diseases 72(Suppl 2), ii56\u201361, https:\/\/doi.org\/10.1136\/annrheumdis-2012-202351 (2013).","journal-title":"Annals of the rheumatic diseases"},{"key":"31116_CR90","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/BOR.0000000000000008","volume":"26","author":"SB Brusca","year":"2014","unstructured":"Brusca, S. B., Abramson, S. B. & Scher, J. U. Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity. Current opinion in rheumatology 26, 101\u2013107, https:\/\/doi.org\/10.1097\/BOR.0000000000000008 (2014).","journal-title":"Current opinion in rheumatology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31116-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31116-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31116-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:49:14Z","timestamp":1671612554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31116-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,27]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["31116"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-31116-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,27]]},"assertion":[{"value":"14 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12863"}}